Department of Radiation Oncology, James Cancer Hospital & Solove Research Institute, The Ohio State University, Columbus, 43210, USA.
Acta Oncol. 2010 Nov;49(8):1269-75. doi: 10.3109/0284186X.2010.509737. Epub 2010 Aug 16.
To analyze published clinical data and provide a preliminary estimate of tumor repopulation rate and its onset time during radiation therapy for prostate cancer.
Data on prostate cancer treated with external beam radiotherapy (EBRT) by Perez et al. (2004), Amdur et al. (1990) and Lai et al. (1991) were analyzed in this study. The stage-combined pelvic control rate from Perez et al. was calculated to be 0.95±0.01, 0.87±0.02, and 0.72±0.04 for patients treated ≤7 weeks, 7.1-9 weeks, and >9 weeks respectively. Based on the Linear-Quadratic model, extended to account for tumor repopulation, the least χ² method was used to fit the clinical data and derive the onset time (T(k)) and effective doubling time (T(d)) for prostate cancer. Similar analysis was performed for the other two datasets.
Best fit was achieved with onset time T(k)=34±7 days and doubling time T(d)=12±2 days. These parameters were independent of the choice of the α/β values currently published in the literature. Analyses of the other two datasets showed T(k)=42±7 days with T(d)=9 ± 3 days, and T(k)=34±6 days with T(d)=34±5 days, respectively. T(k) was found to be dependent on tumor stage.
Consistent values for onset time T(k) were obtained from different datasets, while the range of doubling time T(d) was large. Tumor repopulation starts no later than 58 days (at 90% confidence level) in the course of EBRT for prostate cancer.
分析已发表的临床数据,初步估计前列腺癌放射治疗过程中的肿瘤再增殖率及其发生时间。
本研究分析了 Perez 等人(2004 年)、Amdur 等人(1990 年)和 Lai 等人(1991 年)发表的关于前列腺癌接受外束放射治疗(EBRT)的数据。将 Perez 等人的联合盆腔控制率按阶段计算,分别为≤7 周、7.1-9 周和>9 周治疗的患者为 0.95±0.01、0.87±0.02 和 0.72±0.04。基于扩展到考虑肿瘤再增殖的线性二次模型,使用最小 χ²法拟合临床数据,得出前列腺癌的发生时间(T(k))和有效倍增时间(T(d))。对另外两个数据集进行了类似的分析。
最佳拟合的起始时间 T(k)=34±7 天,倍增时间 T(d)=12±2 天。这些参数与目前文献中公布的 α/β 值的选择无关。对另外两个数据集的分析表明,T(k)=42±7 天,T(d)=9±3 天,T(k)=34±6 天,T(d)=34±5 天。T(k)与肿瘤分期有关。
从不同的数据集中获得了一致的起始时间 T(k)值,而倍增时间 T(d)的范围较大。在前列腺癌 EBRT 过程中,肿瘤再增殖最迟不晚于 58 天(90%置信水平)开始。